| DIRECT COMPETITOR COMPARISON | |
| DDD | BVF | JNJ | SKYEY.PK | Industry | | Market Cap: | 20.96M | 2.22B | 178.93B | N/A | 56.30M | | Employees: | 17 | N/A | 118,700 | N/A | 56 | | Qtrly Rev Growth (yoy): | 10.70% | 17.40% | -5.30% | N/A | 18.90% | | Revenue (ttm): | 841.10K | 760.87M | 60.53B | N/A | 12.73M | | Gross Margin (ttm): | N/A | 71.90% | 71.08% | N/A | 50.63% | | EBITDA (ttm): | -7.54M | 359.76M | 19.05B | N/A | -1.76M | | Oper Margins (ttm): | -948.46% | 30.18% | 26.94% | N/A | -19.80% | | Net Income (ttm): | -7.99M | 223.84M | 12.77B | N/A | N/A | | EPS (ttm): | -0.195 | 1.413 | 4.579 | N/A | N/A | | P/E (ttm): | N/A | 9.91 | 14.16 | N/A | 24.14 | | PEG (5 yr expected): | N/A | 1.38 | 1.9 | N/A | 1.34 | | P/S (ttm): | 24.92 | 2.92 | 2.95 | N/A | 3.39 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.31 | 0.20% | 56.99B | 12.28 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 48.65 | 0.81% | 14.07B | 16.28 | | Genzyme Corp. | GENZ | 49.74 | 0.30% | 13.20B | 28.36 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.42 | 0.28% | 41.77B | 17.95 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.27 | -0.18% | 8.97B | 1025.92 | | Teva Pharmaceutical Industries Limited | TEVA | 52.79 | -0.64% | 46.51B | 48.30 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 38.28 | 0.00% | 4.06B | 19.73 | | King Pharmaceuticals Inc. | KG | 11.61 | -2.03% | 2.88B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.52 | 1.93% | 5.66B | 113.62 | | Pfizer Inc. | PFE | 18.30 | -0.11% | 147.67B | 15.20 | | Johnson & Johnson | JNJ | 64.85 | 0.12% | 178.93B | 14.16 | | GlaxoSmithKline plc | GSK | 42.24 | 0.43% | 107.08B | 13.58 | | Sanofi-Aventis | SNY | 38.50 | -1.13% | 100.53B | N/A | | Novartis AG | NVS | 53.83 | -0.61% | 122.26B | 16.12 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 40.75 | -0.61% | N/A | N/A | | AstraZeneca plc | AZN | 45.68 | 0.73% | 66.24B | 9.17 | | Abbott Laboratories | ABT | 53.77 | -0.55% | 83.17B | 14.57 | | Bristol-Myers Squibb Co. | BMY | 25.80 | 1.02% | 51.11B | 13.35 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|